APO RESEARCH · REPORT
Sphingosine 1-Phosphate Receptor 1
Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.
Product & engineering
Understand the product.
Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.
Selected research
Market Analysis & Forecast
Global Sphingosine 1-Phosphate Receptor 1 Market Analysis and Forecast 2026-2032
Market perspective
Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.
In the last several years, global market of Sphingosine 1-Phosphate Receptor 1 developed rapidly, with an average growth rate of 3.5%, Sphingosine 1-Phosphate Receptor 1 is widely used in Hospital, Clinic. North America is the largest consumption place, with a revenue market share nearly 57.1% in 2019,. and market competition is not intense.
This report presents an overview of global market for Sphingosine 1-Phosphate Receptor 1, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
Read the full market overview
This report researches the key producers of Sphingosine 1-Phosphate Receptor 1, also provides the sales of main regions and countries. Of the upcoming market potential for Sphingosine 1-Phosphate Receptor 1, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sphingosine 1-Phosphate Receptor 1 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Sphingosine 1-Phosphate Receptor 1 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Sphingosine 1-Phosphate Receptor 1 sales, projected growth trends, production technology, application and end-user industry.
Sphingosine 1-Phosphate Receptor 1 Segment by Company
Novartis AG
Bristol-Myers Squibb Company
Sphingosine 1-Phosphate Receptor 1 Segment by Type
Fingolimod
Siponimod
Ozanimod
Other
Sphingosine 1-Phosphate Receptor 1 Segment by Application
Hospital
Clinic
Other
Sphingosine 1-Phosphate Receptor 1 Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sphingosine 1-Phosphate Receptor 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sphingosine 1-Phosphate Receptor 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sphingosine 1-Phosphate Receptor 1.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Sphingosine 1-Phosphate Receptor 1 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Sphingosine 1-Phosphate Receptor 1 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sphingosine 1-Phosphate Receptor 1 sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fingolimod
- Siponimod
- Ozanimod
- Other
Applications
- Hospital
- Clinic
- Other
Companies covered
- Novartis AG
- Bristol-Myers Squibb Company
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Sphingosine 1-Phosphate Receptor 1 Market by Type
- 1.2.1 Global Sphingosine 1-Phosphate Receptor 1 Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Fingolimod
- 1.2.3 Siponimod
- 1.2.4 Ozanimod
- 1.2.5 Other
- 1.3 Sphingosine 1-Phosphate Receptor 1 Market by Application
- 1.3.1 Global Sphingosine 1-Phosphate Receptor 1 Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Sphingosine 1-Phosphate Receptor 1 Market Dynamics
- 2.1 Sphingosine 1-Phosphate Receptor 1 Industry Trends
- 2.2 Sphingosine 1-Phosphate Receptor 1 Industry Drivers
- 2.3 Sphingosine 1-Phosphate Receptor 1 Industry Opportunities and Challenges
- 2.4 Sphingosine 1-Phosphate Receptor 1 Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Sphingosine 1-Phosphate Receptor 1 Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Region
- 3.2.1 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Region (2021-2026)
- 3.2.3 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Region (2027-2032)
- 3.2.4 Global Sphingosine 1-Phosphate Receptor 1 Revenue Market Share by Region (2021-2032)
- 3.3 Global Sphingosine 1-Phosphate Receptor 1 Sales Estimates and Forecasts 2021-2032
- 3.4 Global Sphingosine 1-Phosphate Receptor 1 Sales by Region
- 3.4.1 Global Sphingosine 1-Phosphate Receptor 1 Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Sphingosine 1-Phosphate Receptor 1 Sales by Region (2021-2026)
- 3.4.3 Global Sphingosine 1-Phosphate Receptor 1 Sales by Region (2027-2032)
- 3.4.4 Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Manufacturers
- 4.1.1 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Sphingosine 1-Phosphate Receptor 1 Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Sphingosine 1-Phosphate Receptor 1 Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Sphingosine 1-Phosphate Receptor 1 Sales by Manufacturers
- 4.2.1 Global Sphingosine 1-Phosphate Receptor 1 Sales by Manufacturers (2021-2026)
- 4.2.2 Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Sphingosine 1-Phosphate Receptor 1 Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Sphingosine 1-Phosphate Receptor 1 Sales Price by Manufacturers (2021-2026)
- 4.4 Global Sphingosine 1-Phosphate Receptor 1 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Sphingosine 1-Phosphate Receptor 1 Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Sphingosine 1-Phosphate Receptor 1 Manufacturers, Product Type & Application
- 4.7 Global Sphingosine 1-Phosphate Receptor 1 Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Sphingosine 1-Phosphate Receptor 1 Market CR5 and HHI
- 4.8.2 2025 Sphingosine 1-Phosphate Receptor 1 Tier 1, Tier 2, and Tier 3
5 Sphingosine 1-Phosphate Receptor 1 Market by Type
- 5.1 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Type
- 5.1.1 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Sphingosine 1-Phosphate Receptor 1 Revenue Market Share by Type (2021-2032)
- 5.2 Global Sphingosine 1-Phosphate Receptor 1 Sales by Type
- 5.2.1 Global Sphingosine 1-Phosphate Receptor 1 Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Sphingosine 1-Phosphate Receptor 1 Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Type (2021-2032)
- 5.3 Global Sphingosine 1-Phosphate Receptor 1 Price by Type
6 Sphingosine 1-Phosphate Receptor 1 Market by Application
- 6.1 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Application
- 6.1.1 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Sphingosine 1-Phosphate Receptor 1 Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Sphingosine 1-Phosphate Receptor 1 Revenue Market Share by Application (2021-2032)
- 6.2 Global Sphingosine 1-Phosphate Receptor 1 Sales by Application
- 6.2.1 Global Sphingosine 1-Phosphate Receptor 1 Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Sphingosine 1-Phosphate Receptor 1 Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Sphingosine 1-Phosphate Receptor 1 Sales Market Share by Application (2021-2032)
- 6.3 Global Sphingosine 1-Phosphate Receptor 1 Price by Application
7 Company Profiles
- 7.1 Novartis AG
- 7.1.1 Novartis AG Company Information
- 7.1.2 Novartis AG Business Overview
- 7.1.3 Novartis AG Sphingosine 1-Phosphate Receptor 1 Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Novartis AG Sphingosine 1-Phosphate Receptor 1 Product Portfolio
- 7.1.5 Novartis AG Recent Developments
- 7.2 Bristol-Myers Squibb Company
- 7.2.1 Bristol-Myers Squibb Company Company Information
- 7.2.2 Bristol-Myers Squibb Company Business Overview
- 7.2.3 Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Bristol-Myers Squibb Company Sphingosine 1-Phosphate Receptor 1 Product Portfolio
- 7.2.5 Bristol-Myers Squibb Company Recent Developments
8 North America
- 8.1 North America Sphingosine 1-Phosphate Receptor 1 Market Size by Type
- 8.1.1 North America Sphingosine 1-Phosphate Receptor 1 Revenue by Type (2021-2032)
- 8.1.2 North America Sphingosine 1-Phosphate Receptor 1 Sales by Type (2021-2032)
- 8.1.3 North America Sphingosine 1-Phosphate Receptor 1 Price by Type (2021-2032)
- 8.2 North America Sphingosine 1-Phosphate Receptor 1 Market Size by Application
- 8.2.1 North America Sphingosine 1-Phosphate Receptor 1 Revenue by Application (2021-2032)
- 8.2.2 North America Sphingosine 1-Phosphate Receptor 1 Sales by Application (2021-2032)
- 8.2.3 North America Sphingosine 1-Phosphate Receptor 1 Price by Application (2021-2032)
- 8.3 North America Sphingosine 1-Phosphate Receptor 1 Market Size by Country
- 8.3.1 North America Sphingosine 1-Phosphate Receptor 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Sphingosine 1-Phosphate Receptor 1 Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Sphingosine 1-Phosphate Receptor 1 Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Sphingosine 1-Phosphate Receptor 1 Market Size by Type
- 9.1.1 Europe Sphingosine 1-Phosphate Receptor 1 Revenue by Type (2021-2032)
- 9.1.2 Europe Sphingosine 1-Phosphate Receptor 1 Sales by Type (2021-2032)
- 9.1.3 Europe Sphingosine 1-Phosphate Receptor 1 Price by Type (2021-2032)
- 9.2 Europe Sphingosine 1-Phosphate Receptor 1 Market Size by Application
- 9.2.1 Europe Sphingosine 1-Phosphate Receptor 1 Revenue by Application (2021-2032)
- 9.2.2 Europe Sphingosine 1-Phosphate Receptor 1 Sales by Application (2021-2032)
- 9.2.3 Europe Sphingosine 1-Phosphate Receptor 1 Price by Application (2021-2032)
- 9.3 Europe Sphingosine 1-Phosphate Receptor 1 Market Size by Country
- 9.3.1 Europe Sphingosine 1-Phosphate Receptor 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Sphingosine 1-Phosphate Receptor 1 Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Sphingosine 1-Phosphate Receptor 1 Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Sphingosine 1-Phosphate Receptor 1 Market Size by Type
- 10.1.1 China Sphingosine 1-Phosphate Receptor 1 Revenue by Type (2021-2032)
- 10.1.2 China Sphingosine 1-Phosphate Receptor 1 Sales by Type (2021-2032)
- 10.1.3 China Sphingosine 1-Phosphate Receptor 1 Price by Type (2021-2032)
- 10.2 China Sphingosine 1-Phosphate Receptor 1 Market Size by Application
- 10.2.1 China Sphingosine 1-Phosphate Receptor 1 Revenue by Application (2021-2032)
- 10.2.2 China Sphingosine 1-Phosphate Receptor 1 Sales by Application (2021-2032)
- 10.2.3 China Sphingosine 1-Phosphate Receptor 1 Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Sphingosine 1-Phosphate Receptor 1 Market Size by Type
- 11.1.1 Asia Sphingosine 1-Phosphate Receptor 1 Revenue by Type (2021-2032)
- 11.1.2 Asia Sphingosine 1-Phosphate Receptor 1 Sales by Type (2021-2032)
- 11.1.3 Asia Sphingosine 1-Phosphate Receptor 1 Price by Type (2021-2032)
- 11.2 Asia Sphingosine 1-Phosphate Receptor 1 Market Size by Application
- 11.2.1 Asia Sphingosine 1-Phosphate Receptor 1 Revenue by Application (2021-2032)
- 11.2.2 Asia Sphingosine 1-Phosphate Receptor 1 Sales by Application (2021-2032)
- 11.2.3 Asia Sphingosine 1-Phosphate Receptor 1 Price by Application (2021-2032)
- 11.3 Asia Sphingosine 1-Phosphate Receptor 1 Market Size by Country
- 11.3.1 Asia Sphingosine 1-Phosphate Receptor 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Sphingosine 1-Phosphate Receptor 1 Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Sphingosine 1-Phosphate Receptor 1 Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Sphingosine 1-Phosphate Receptor 1 Market Size by Type
- 12.1.1 SAMEA Sphingosine 1-Phosphate Receptor 1 Revenue by Type (2021-2032)
- 12.1.2 SAMEA Sphingosine 1-Phosphate Receptor 1 Sales by Type (2021-2032)
- 12.1.3 SAMEA Sphingosine 1-Phosphate Receptor 1 Price by Type (2021-2032)
- 12.2 SAMEA Sphingosine 1-Phosphate Receptor 1 Market Size by Application
- 12.2.1 SAMEA Sphingosine 1-Phosphate Receptor 1 Revenue by Application (2021-2032)
- 12.2.2 SAMEA Sphingosine 1-Phosphate Receptor 1 Sales by Application (2021-2032)
- 12.2.3 SAMEA Sphingosine 1-Phosphate Receptor 1 Price by Application (2021-2032)
- 12.3 SAMEA Sphingosine 1-Phosphate Receptor 1 Market Size by Country
- 12.3.1 SAMEA Sphingosine 1-Phosphate Receptor 1 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Sphingosine 1-Phosphate Receptor 1 Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Sphingosine 1-Phosphate Receptor 1 Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Sphingosine 1-Phosphate Receptor 1 Value Chain Analysis
- 13.1.1 Sphingosine 1-Phosphate Receptor 1 Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Sphingosine 1-Phosphate Receptor 1 Production Mode & Process
- 13.2 Sphingosine 1-Phosphate Receptor 1 Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Sphingosine 1-Phosphate Receptor 1 Distributors
- 13.2.3 Sphingosine 1-Phosphate Receptor 1 Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst